^
BIOMARKER:

MAP2K1 P124L

i
Other names: MAP2K1, MAPKK1, MEK1, PRKMK1, Mitogen-activated protein kinase kinase 1
Entrez ID:
Related biomarkers:
MAP2K1 P124L
Melanoma
selumetinib
Resistant: C3 – Early Trials
MAP2K1 P124L
Melanoma
dabrafenib
Resistant: C3 – Early Trials
MAP2K1 P124L
Melanoma
vemurafenib
Resistant: C3 – Early Trials
MAP2K1 P124L
Melanoma
temozolomide
Sensitive: C4 – Case Studies
MAP2K1 P124L
Melanoma
VTX-11e
Sensitive: D – Preclinical
MAP2K1 P124L
Melanoma
trametinib
Sensitive: D – Preclinical